PMVP
Pmv Pharmaceuticals Inc
NASDAQ: PMVP · HEALTHCARE · BIOTECHNOLOGY
$1.38
+10.40% today
Updated 2026-10-28
Market cap
$91.37M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.42
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$4.20
+204.35%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -1.25 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-14.58M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-73.32M | $-68.96M | $-58.71M | $-77.74M | $-18.09M |
| EPS | — | — | — | — | $-1.42 |
| Free cash flow | $-71.74M | $-56.62M | $-51.94M | $-73.61M | $-14.58M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Pmv Pharmaceuticals Inc trades at $1.38. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -1.25, it sits in the distress.
Frequently asked questions
What is Pmv Pharmaceuticals Inc's stock price?
Pmv Pharmaceuticals Inc (PMVP) trades at $1.38.
Is Pmv Pharmaceuticals Inc overvalued?
Pmv Pharmaceuticals Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Pmv Pharmaceuticals Inc (PMVP)?
The 12-month analyst consensus target is $4.20, about 204.3% above the current $1.38. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Pmv Pharmaceuticals Inc's Altman Z-Score is -1.25, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-89.06%
Beta1.35
50D MA$1.37
200D MA$1.30
Shares out0.08B
Float0.04B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—